Determinants of changes in lipid levels in a prophylactic programme

[1] Maniecka-Bryła I., Pikala M., Bryła M., Life years lost due to cardiovascular diseases. Kardiol. Pol. 2013, 71, 293–300 10.5603/KP.2013.0262Search in Google Scholar

[2] Maniecka-Bryła I., Pikala M., Bryła M., Health inequalities among rural and urban inhabitants of Łódź province, Poland. Ann. Agric. Environ. Med. 2012, 19, 723–731 Search in Google Scholar

[3] Maniecka-Bryła I, Maciak-Andrzejewska A, Bryła M, Bojar I, An assessment of health effects of a cardiological prophylaxis programme in a local community with the use of the SCORE algorithm. Ann. Agric. Environ. Med. 2013. 20,794–799 Search in Google Scholar

[4] Mckee M., Perry I., Ischaemic heart disease — more than just lipids. Eur. J. Public Health 2002, 12, 241–242 http://dx.doi.org/10.1093/eurpub/12.4.24110.1093/eurpub/12.4.241Search in Google Scholar

[5] Bryła M., Maciak-Andrzejewska A., Maniecka-Bryła I., Częstość wybranych czynników ryzyka chorób układu krążenia w zależności od charakteru wykonywanej pracy. Med. Pr. 2013, 64, 307–315 Search in Google Scholar

[6] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106, 3143–3421 10.1161/circ.106.25.3143Search in Google Scholar

[7] Pająk A., Wiercińska E., Polakowska M., Kozakiewicz K., Kaczmarczyk-Chałas K., Tykarski A. i in., Rozpowszechnienie dyslipidemii u mężczyzn i kobiet w wieku 20–74 lata w Polsce. Wyniki programu WOBASZ. Kardiol. Pol. 2005, 63,supl. 4, 1–4 Search in Google Scholar

[8] Zdrojewski T., Bandosz P., Szpakowski P. Konarski R., Manikowski A., Wołkiewicz E. i in., Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol. Pol. 2004, 61,supl. 1, 1–26 Search in Google Scholar

[9] Mastej M., Jóźwiak J., Lukas W. Piwowarska W., Tykarski A., Orzechowski M., Ocena i porównanie parametrów lipidogramu w zależności od płci oraz wskaźnika masy ciała BMI. Kardiol. Pol. 2006, 64, supl. 2, 153–160 Search in Google Scholar

[10] Ministry of Health — National Health Plan for years 2004–2013. Warsaw, Poland, 2003; 262–263 Search in Google Scholar

[11] Narodowy Program Zdrowia 2007–2015, Ministerstwo Zdrowia, Warszawa 2007 Search in Google Scholar

[12] Lorezno C., Williams K., Hunt K. Haffner S.M., The National Cholesterol Education Program — Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care, 2007, 30, 8–13 http://dx.doi.org/10.2337/dc06-141410.2337/dc06-1414Search in Google Scholar

[13] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation, 2002, 106, 3143 10.1161/circ.106.25.3143Search in Google Scholar

[14] Arnett D.K., Jacobs D.R., Luepker R.V., Blackburn H,, Armstrong C, Claas S.A., Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation 2005, 112, 3884–3891 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.54985710.1161/CIRCULATIONAHA.105.549857Search in Google Scholar

[15] Rysz J., Banach M., Stolarek R., Irzmański R., Markuszewski L., Wilk R., The lipid disorders therapy in overweight patients. Arch. Med. Sci. 2005, 1, 241–245 Search in Google Scholar

[16] Batic-Mujanovic O., Beganlic A., Salihefendic N. Pranjic N., Kusljugic Z., Influence of smoking on serum lipid and lipoprotein levels among family medicine patients. Med. Arh. 2008, 62, 264–267 Search in Google Scholar

[17] Nakamura K., Barzi F., Huxley R., Lam T.H., Suh I., Woo J. et. al., Asia Pacific Cohort Studies Collaboration: Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart, 2009, 95, 909–916 http://dx.doi.org/10.1136/hrt.2008.14706610.1136/hrt.2008.147066Search in Google Scholar

[18] Noguchi Y., Fukui T., The effects of cessation from cigarette smoking on the lipid and lipoprotein pro- files: a meta-analysis. Prev. Med. 2003. 37. 283–90 http://dx.doi.org/10.1016/S0091-7435(03)00110-510.1016/S0091-7435(03)00110-5Search in Google Scholar

[19] Piper M.E., Johnson H.M., Fiore M.C., Baker T.B., Stein J.H., Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am. Heart J. 2011, 161, 145–151 http://dx.doi.org/10.1016/j.ahj.2010.09.02310.1016/j.ahj.2010.09.023Search in Google Scholar PubMed PubMed Central

[20] De Miguel-Díez J., Carrasco-Garrido P., Rejas-Gutierrez J. Martín-Centeno A., Gobartt-Vázquez E., Hernandez-Barrera V., et al., The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. Cardiovascular Disorders, 2010, 10, 8–17 http://dx.doi.org/10.1186/1471-2261-10-810.1186/1471-2261-10-8Search in Google Scholar PubMed PubMed Central

[21] European Hearth Health Charter — European Society of Cardiology and the European Heart Network; Brussels 2007: 10 Search in Google Scholar

[22] Kirkwood L., Aldujaili E., Drummond S., Effects of advice on dietary intake and/or physical activity on body composition, blood lipids and insulin resistance following a low-fat, sucrose-containing, highcarbohydrate, energy-restricted diet. Int. J. Food Sci. Nutr. 2007, 58, 383–397 http://dx.doi.org/10.1080/0963748070125233610.1080/09637480701252336Search in Google Scholar PubMed

[23] Ainslie P.N., Reilly T., Maclaren D.P., Campbell I.T., Changes in plasma lipids and lipoproteins following 10-days of prolonged walking: influence of age and relationship to physical activity level. Ergonomics 2005. 48, 1352–1364 http://dx.doi.org/10.1080/0014013050010113010.1080/00140130500101130Search in Google Scholar PubMed

[24] Skoumas J., Pitsavos C., Panagiotakos D.B., Chrysohoou C., Zeimbekis A., Papaioannou I., et al., Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids in Health and Disease, 2003, 2, 3–11 http://dx.doi.org/10.1186/1476-511X-2-310.1186/1476-511X-2-3Search in Google Scholar PubMed PubMed Central

[25] Pelletier D.L., Baker P.T., Physical activity and plasma total- and HDL-cholesterol levels in Western Samoan men. AJCN 1987, 46, 577–585 10.1093/ajcn/46.4.577Search in Google Scholar PubMed

[26] Gordon L., Ragoobirsingh D., Morrison E., McGrowder D., Choo-Kang E., Martorell E., Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch. Med. Sci. 2010, 6, 701–708 http://dx.doi.org/10.5114/aoms.2010.1708410.5114/aoms.2010.17084Search in Google Scholar PubMed PubMed Central